Levofloxacin vs Pembrolizumab
Levofloxacin vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Levofloxacin and Pembrolizumab.
Mechanism of Action
Levofloxacin: Fluoroquinolone antibiotic inhibiting bacterial DNA gyrase and topoisomerase IV.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Levofloxacin β 6-8 hours; Pembrolizumab β 26 days.
Chemical Properties
Molecular Formula: Levofloxacin β C18H20FN3O4.
Molecular Weight: Levofloxacin β 361.3680 g/mol.
Type: Levofloxacin β Small molecule; Pembrolizumab β Antibody.